Skip to main content
SpringerLink
Log in

Choosing between PCV10 and PCV13: price matters

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2013 US dollars

  2. invasive pneumococcal disease including bacteraemia, meningitis, peritonitis and sepsis

  3. acute otitis media

Reference

  • Bin-Chia Wu D, et al. Choosing between 7-, 10- and 13-valent pneumococcal conjugate vaccines in childhood: A review of economic evaluations (2006-2014). Vaccine : 11 Feb 2015. Available from: URL: http://doi.org/10.1016/j.vaccine.2015.01.081

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Choosing between PCV10 and PCV13: price matters. PharmacoEcon Outcomes News 722, 7 (2015). https://doi.org/10.1007/s40274-015-1913-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-1913-4

Search

Navigation